Literature DB >> 23841024

Mouse models for colorectal cancer.

Baktiar O Karim1, David L Huso.   

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer-related death in the United States, with the number of affected people increasing. There are many risk factors that increase CRC risk, including family or personal history of CRC, smoking, consumption of red meat, obesity, and alcohol consumption. Conversely, increased screening, maintaining healthy body weight, not smoking, and limiting intake of red meat are all associated with reduced CRC morbidity and mortality. Mouse models of CRC were first used in 1928 and have played an important role in understanding CRC biology and treatment and have long been instrumental in clarifying the pathobiology of CRC formation and inhibition. This review focuses on advancements in modeling CRC in mice.

Entities:  

Keywords:  Apc; Colorectal cancer; FAP; HNPCC; human; mouse models; stem cells; tumorigenesis

Year:  2013        PMID: 23841024      PMCID: PMC3696531     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  106 in total

1.  Intestinal crypt clonogens: a new interpretation of radiation survival curve shape and clonogenic cell number.

Authors:  S A Roberts; J H Hendry; C S Potten
Journal:  Cell Prolif       Date:  2003-08       Impact factor: 6.831

2.  Bmi1 is expressed in vivo in intestinal stem cells.

Authors:  Eugenio Sangiorgi; Mario R Capecchi
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

3.  Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity.

Authors:  P Kaur; C S Potten
Journal:  Cell Tissue Kinet       Date:  1986-11

4.  Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

Authors:  Ulrike Sack; Wolfgang Walther; Dominic Scudiero; Mike Selby; Dennis Kobelt; Margit Lemm; Iduna Fichtner; Peter M Schlag; Robert H Shoemaker; Ulrike Stein
Journal:  J Natl Cancer Inst       Date:  2011-06-17       Impact factor: 13.506

5.  Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Authors:  Elizabeth H Ruder; Adeyinka O Laiyemo; Barry I Graubard; Albert R Hollenbeck; Arthur Schatzkin; Amanda J Cross
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

6.  1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.

Authors:  C Colussi; S Fiumicino; A Giuliani; S Rosini; P Musiani; C Macrí; C S Potten; M Crescenzi; M Bignami
Journal:  J Natl Cancer Inst       Date:  2001-10-17       Impact factor: 13.506

7.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

Authors:  Melanie H Kucherlapati; Kyeryoung Lee; Andrew A Nguyen; Alan B Clark; Harry Hou; Andrew Rosulek; Hua Li; Kan Yang; Kunhua Fan; Martin Lipkin; Roderick T Bronson; Linda Jelicks; Thomas A Kunkel; Raju Kucherlapati; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

8.  Clonal analysis of human colorectal tumors.

Authors:  E R Fearon; S R Hamilton; B Vogelstein
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

9.  A comparison of in vivo cell proliferation measurements in the intestine of mouse and man.

Authors:  M Kellett; C S Potten; D A Rew
Journal:  Epithelial Cell Biol       Date:  1992-10

10.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24
View more
  29 in total

Review 1.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 2.  Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.

Authors:  Arthur Winer; Sylvia Adams; Paolo Mignatti
Journal:  Mol Cancer Ther       Date:  2018-05-07       Impact factor: 6.261

3.  A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase.

Authors:  Jeffrey S Souris; Hannah J Zhang; Urszula Dougherty; Nai-Tzu Chen; Joseph V Waller; Leu-Wei Lo; John Hart; Chin-Tu Chen; Marc Bissonnette
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

4.  Fiber-bundle microendoscopy with sub-diffuse reflectance spectroscopy and intensity mapping for multimodal optical biopsy of stratified epithelium.

Authors:  Gage J Greening; Haley M James; Amy J Powless; Joshua A Hutcheson; Mary K Dierks; Narasimhan Rajaram; Timothy J Muldoon
Journal:  Biomed Opt Express       Date:  2015-11-19       Impact factor: 3.732

Review 5.  Development of Preclinical Models to Understand and Treat Colorectal Cancer.

Authors:  Judith S Sebolt-Leopold
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

6.  Viral oncogene expression in the stem/progenitor cell compartment of the mouse intestine induces adenomatous polyps.

Authors:  Maria Teresa Sáenz Robles; Jean Leon Chong; Christopher Koivisto; Anthony Trimboli; Huayang Liu; Gustavo Leone; James M Pipas
Journal:  Mol Cancer Res       Date:  2014-07-03       Impact factor: 5.852

7.  Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.

Authors:  Shakir M Saud; Weidong Li; Nicole L Morris; Matthias S Matter; Nancy H Colburn; Young S Kim; Matthew R Young
Journal:  Carcinogenesis       Date:  2014-10-03       Impact factor: 4.944

Review 8.  Mouse models for the discovery of colorectal cancer driver genes.

Authors:  Christopher R Clark; Timothy K Starr
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

9.  STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models.

Authors:  Francesca Marino; Valeria Orecchia; Gabriella Regis; Monica Musteanu; Beatrice Tassone; Cristina Jon; Marco Forni; Enzo Calautti; Roberto Chiarle; Robert Eferl; Valeria Poli
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

10.  Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon.

Authors:  Kathryn E Hamilton; Priya Chatterji; Emma T Lundsmith; Sarah F Andres; Veronique Giroux; Philip D Hicks; Felicite K Noubissi; Vladimir S Spiegelman; Anil K Rustgi
Journal:  Mol Cancer Res       Date:  2015-07-20       Impact factor: 6.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.